Probiotics & Gastrointestinal Diseases
Dysbiosis and Prematurity: Is There a Role for Probiotics?
Probiotics for antibiotic-associated diarrhea: do we have a verdict?
Probiotics, enteric and diarrheal diseases, and global health.
Probiotics for Gastrointestinal Conditions: A Summary of the Evidence.
Role of Probiotics in Human Gut Microbiome-Associated Diseases.
Probiotics and necrotizing enterocolitis.
How Probiotics Affect the Microbiota.
Probiotics and oral health: A systematic review.
Probiotics and the Gut Immune System: Indirect Regulation.
Probiotics for treating acute infectious diarrhoea.
Probiotics on Pediatric Functional Gastrointestinal Disorders.
Helicobacter pylori treatment: antibiotics or probiotics.
Systematic review: probiotics for functional constipation in children.
Probiotics in the Treatment of Diverticular Disease. A Systematic Review.
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Probiotics to prevent infantile colic.
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
Probiotics in inflammatory bowel disease: is it all gut flora modulation?
Prebiotics in chronic intestinal inflammation.
Probiotics for prevention of Clostridium difficile infection.
Overview of the phytomedicine approaches against Helicobacter pylori.
Symbiotics in irritable bowel syndrome--better than probiotics alone?
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Potential Mechanisms of Probiotics Action in the Prevention and Treatment of Colorectal Cancer.
Probiotics in preventing and treating chemotherapy-induced diarrhea: a meta-analysis.
Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review.
Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration.
Role of the microbiome, probiotics, and 'dysbiosis therapy' in critical illness.
Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy.
Can probiotics modulate human disease by impacting intestinal barrier function?
Efficacy and safety of probiotics in eradicating Helicobacter pylori: A network meta-analysis.
hospitalized patients: systematic review and meta-analysis.
Probiotics and the gut microbiota in intestinal health and disease.
Gastroesophageal Reflux Disease and Probiotics: A Systematic Review.
Review and Meta-Analysis of Randomized Controlled Trials.
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.
evidence-based international guide.
Probiotic Species in the Modulation of Gut Microbiota: An Overview.
Probiotics and necrotizing enterocolitis.
Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea.
Probiotics: current trends in the treatment of diarrhoea.
Probiotics and irritable bowel syndrome.
Impact of probiotics on necrotizing enterocolitis.
Probiotics in clostridium difficile Infection.
Probiotics for treating persistent diarrhoea in children.
[Probiotics for the treatment of infant colic: a clinical case].
Probiotics for induction of remission in Crohn's disease.
Rebuilding the Gut Microbiota Ecosystem.
Probiotics for preventing gestational diabetes.
Probiotics: progress toward novel therapies for intestinal diseases.
Probiotics for infectious diarrhoea.
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis.
Probiotics and remission of ulcerative colitis: a systematic review.
A gastroenterologist's guide to probiotics.
Probiotics and inflammatory bowel diseases.
[Use of probiotics in the prevention of necrotizing enterocolitis in premature newborns].
Probiotics in inflammatory bowel diseases and associated conditions.
Probiotics and barrier function in colitis.
Probiotics for infantile colic: a systematic review.
Do probiotics have a therapeutic role in gastroenterology?
Probiotics and the gastrointestinal tract: where are we in 2005?
Bioengineered probiotics, a strategic approach to control enteric infections.
Are probiotics useful in Helicobacter pylori eradication?
Arguments for routine administration of probiotics for NEC prevention.
Probiotics and inflammatory bowel disease.
THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review.
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
Systematic review of probiotics for the treatment of community-acquired acute diarrhea in children.
Probiotics in inflamatory bowel disease.
Recent advances in understanding and managing infantile colic.
A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome.
Role of probiotics in short bowel syndrome in infants and children--a systematic review.
A meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates.
Probiotics--scope and promise in inflammatory bowel disease.
Meta-analysis of probiotics for the treatment of irritable bowel syndrome.
Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy.
Probiotics: a role in the treatment of intestinal infection and inflammation?
[Helicobacter pylori infection and probiotics].
Probiotics in irritable bowel syndrome.
Review article: probiotics and prebiotics in irritable bowel syndrome.
Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.
Efficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis.
L. casei, and L. rhamnosus strains: assessing the evidence.
Systematic review of randomised controlled trials: probiotics for functional constipation.
Review article: antibiotics and probiotics in inflammatory bowel disease.
Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
Probiotics in the management of inflammatory bowel disease.
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
Helicobacter pylori therapy in children: overview and challenges.
[Irritable Bowel Syndrome; gut microbiota and probiotic therapy].
Looking for new treatments of Infantile Colic.
The therapeutic effect of probiotic bacteria on gastrointestinal diseases.
Saccharomyces boulardii effects on gastrointestinal diseases.
Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Functional gastrointestinal disorders in newborns: nutritional perspectives.
Management and treatment of lactose malabsorption.
Lactocepin as a protective microbial structure in the context of IBD.
Probiotic agents in the treatment of irritable bowel syndrome.
Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.
Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.
Diet therapy for inflammatory bowel diseases: The established and the new.
Necrotizing enterocolitis: old problem with new hope.
[Non-antibiotic treatments for infectious enterocolitis].
Alternative therapies for Helicobacter pylori: probiotics and phytomedicine.
and Meta-Analysis of Randomized Controlled Trials.
Novel approaches to treating Clostridium difficile-associated colitis.
Dysbiosis in Functional Bowel Disorders.
Dietary interventions for recurrent abdominal pain in childhood.
Targeting the gut microbiota for the treatment of irritable bowel syndrome.